Acurx pharmaceuticals, inc. reports fourth quarter and full year 2022 results and provides business update

Staten island, n.y. , march 16, 2023 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational results for the fourth quarter and full year ended december 31, 2022.
ACXP Ratings Summary
ACXP Quant Ranking